EA
AGN

Emerald Acquisition’s Allergan plc AGN Stock Holding History

Emerald Acquisition’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$224M Sell
973,397
-29,454
-3% -$7.2M 0.43% 30
2016
Q2 		$232M Buy
+1,002,851
New +$231M 0.4% 36

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's AGN Position: Q3 2016 in Review

Emerald Acquisition reduced its Allergan plc (AGN) stake by 2.9% in Q3 2016, selling an estimated $7.2M and leaving 973,397 shares worth $224M. The position accounts for 0.43% of the portfolio, ranked #30.

Emerald Acquisition first reported a position in AGN in Q2 2016 and has held it in 2 quarters since. The position peaked at $232M in Q2 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Emerald Acquisition held 973,397 shares of Allergan plc worth $224M as of Q3 2016.
  • Emerald Acquisition sold 29,454 Allergan plc shares in Q3 2016, an estimated $7.2M.
  • Allergan plc made up 0.43% of Emerald Acquisition's portfolio in Q3 2016, its #30 holding.
  • Emerald Acquisition first reported a position in Allergan plc in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Allergan plc position peaked at $232M in Q2 2016.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.